In response to the rulings of the Patents Court within the High Court of Justice for England & Wales on 18th February 2021

MGI makes the following statement: We welcome the Court’s decision to give us the permission to appeal the judgment, and we intend to file its appeal with the Court of Appeal. As permitted by the Court, we will continue to supply sequencing reagents to our existing customers in the UK during the appeal period. Although MGI [...]

HORIBA FRANCE SAS and GreenTropism SAS to Collaborate on Smart Solutions for Processing and Analysis of Spectroscopic Images

Palaiseau, Saclay Campus, France - HORIBA and GreenTropism have signed, 4th January 2021, a collaboration agreement. The two companies will combine their technologies for the development and commercialization of smart solutions combining HORIBA’s spectroscopic and hyperspectral imaging and GreenTropism’s data processing methods enhanced and automated by Artificial Intelligence. This collaboration will allow their respective and common [...]

Phenomenex Introduces NEW SINGLE GC Solution for Dioxin Analysis

Torrance, Calif. – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences introduces Zebron™ ZB-Dioxin . Zebron ZB-Dioxin joins Phenomenex’s large family of GC unlimited Phase to deliver optimal performance when analyzing polychlorinated biphenyls (PCBs) and Dioxins regulated such as 2,3,7,8-tetrachlorodibenzo- para-dioxin (2,3,7,8-TCDD) and 2,3,7,8 tetrachlorodibenzo- para-furan(TCDF). EPA-1613 [...]

RedShift BioAnalytics Announces 500% Sales Growth in 2020 and Closing of Additional Financing

Orders for the company’s AQS3pro™ platform grew over 500% in the second full year since product launch, and the company closed a $6.4 million Series D Preferred Stock extension to support continued aggressive growth in 2021. Burlington, MA – February 18th, 2021  RedShift BioAnalytics, Inc. (www.redshiftbio.com), a provider of innovative analytical solutions for protein characterization used [...]

Our first digital dissolution tester DT 950 Series

The new ERWEKA DT 950 Series is our first digital dissolution tester, equipped with the most advanced embedded PC technology for the requirements of today and the challenges of tomorrow. ERWEKA GmbH is proud to announce the release of its first digital Dissolution Tester - the ERWEKA DT 950 series. Equipped with groundbreaking embedded PC [...]

Yokogawa Adds New Turbidity and Chlorine Analyzers to OpreX Analyzers Lineup

- Bringing high-quality drinking water to the world - Tokyo, Japan -- Yokogawa Electric Corporation (TOKYO: 6841) announces the addition of the TB820D right angle scattered light turbidity detector, FC800D non-reagent type free available chlorine sensor unit, RC800D reagent type residual chlorine sensor unit, FLXA402T liquid analyzer for turbidity and chlorine, and PG400 pulse generator [...]

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the new investigator-initiated study, called the Ge-Med [...]

Quantum-Si, a Pioneer in Semiconductor Chip-Based Proteomics, to Combine with HighCape Capital Acquisition Corp.

HighCape Capital Acquisition Corporation The transaction will merge Quantum-Si’s revolutionary, end-to-end proteomics solution, and HighCape Capital Acquisition Corp., a healthcare-focused SPAC sponsored by leading healthcare growth equity investment firm HighCape Capital LP. The transaction is further supported by an oversubscribed $425 million PIPE with participation from leading institutional investors, including Foresite Capital Management, LLC, Eldridge, [...]

QIAGEN announces Digital Partner Program with five initial partnerships

Partner program designed to advance Sample to Insight solutions from research to patients leveraging QIAGEN’s unique Knowledge Base Five initial partners sign with QIAGEN Digital Insights (QDI) to grow QIAGENs unique genomic Knowledge Base and accelerate access New partnerships to deliver improved AI services and databases in oncology, secondary analysis and combined NGS panels and [...]

Parse Biosciences Launches Whole Transcriptome Kit to Dramatically Scale Single-Cell Sequencing

Parse Biosciences (https://www.parsebiosciences.com/), a company providing researchers with scalable and flexible single-cell sequencing solutions, announced the launch of its Single Cell Whole Transcriptome Kit. The kit, which was previously available only through Parse’s early-access program, is now generally available to all researchers in North America. The Whole Transcriptome Kit from Parse Biosciences contains everything needed [...]

Access IBO on Knowledge Center